| EP0618900 - SUBSTITUTED TETRAHYDROISOQUINOLINES AND THEIR USE AS THERAPEUTIC AGENTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.01.1998 Database last updated on 07.04.2026 | Most recent event Tooltip | 16.01.1998 | No opposition filed within time limit | published on 04.03.1998 [1998/10] | Applicant(s) | For all designated states KNOLL AG Knollstrasse 50 67061 Ludwigshafen / DE | [N/P] |
| Former [1996/02] | For all designated states Knoll AG Knollstrasse D-67061 Ludwigshafen / DE | ||
| Former [1994/41] | For all designated states The Boots Company PLC 1 Thane Road West Nottingham Nottinghamshire NG2 3AA / GB | Inventor(s) | 01 /
KOZLIK, Antonin The Boots Company plc 1 Thane Road West Nottingham NG2 3AA / GB | 02 /
SARGENT, Bruce, Jeremy The Boots Company plc 1 Thane Road West Nottingham NG2 3AA / GB | 03 /
NEEDHAM, Patricia, Lesley The Boots Company plc 1 Thane Road West Nottingham NG2 3AA / GB | [1994/41] | Representative(s) | Bieberbach, Andreas, et al BASF SE Global Intellectual Property GVX / K - C 6 67056 Ludwigshafen / DE | [N/P] |
| Former [1996/02] | Bieberbach, Andreas, Dr., et al BASF Aktiengesellschaft D-67056 Ludwigshafen / DE | ||
| Former [1995/44] | Miller, Thomas Kerr The Boots Company plc, Patents Department, R4 Pennyfoot Street Nottingham NG2 3AA / GB | ||
| Former [1994/41] | Thacker, Michael Anthony THE BOOTS COMPANY PLC Group Patents Department 10th Floor, Newland House 49 Mount Street Nottingham NG2 3AA / GB | Application number, filing date | 93900051.9 | 12.12.1992 | [1994/41] | WO1992EP02900 | Priority number, date | GB19910027306 | 23.12.1991 Original published format: GB 9127306 | [1994/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9313073 | Date: | 08.07.1993 | Language: | EN | [1993/16] | Type: | A1 Application with search report | No.: | EP0618900 | Date: | 12.10.1994 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.07.1993 takes the place of the publication of the European patent application. | [1994/41] | Type: | B1 Patent specification | No.: | EP0618900 | Date: | 12.03.1997 | Language: | EN | [1997/11] | Search report(s) | International search report - published on: | EP | 08.07.1993 | Classification | IPC: | C07D217/04, C07D217/18, C07D217/20, A61K31/47 | [1994/41] | CPC: |
C07D217/20 (EP,US);
A61P25/00 (EP);
A61P25/18 (EP);
A61P25/30 (EP);
C07D217/04 (EP,US);
C07D217/18 (EP,US)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1994/41] | Title | German: | SUBSTITUIERTE TETRAHYDROISOCHINOLIN-DERIVATE UND IHRE ANWENDUNG IN DER THERAPIE | [1994/41] | English: | SUBSTITUTED TETRAHYDROISOQUINOLINES AND THEIR USE AS THERAPEUTIC AGENTS | [1994/41] | French: | TETRAHYDROISOQUINOLEINES SUBSTITUEES ET LEUR UTILISATION COMME AGENTS THERAPEUTIQUES | [1994/41] | Entry into regional phase | 06.06.1994 | National basic fee paid | 06.06.1994 | Designation fee(s) paid | 06.06.1994 | Examination fee paid | Examination procedure | 28.06.1993 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.06.1994 | Examination requested [1994/41] | 19.05.1995 | Despatch of a communication from the examining division (Time limit: M04) | 06.09.1995 | Reply to a communication from the examining division | 22.02.1996 | Despatch of communication of intention to grant (Approval: Yes) | 18.06.1996 | Communication of intention to grant the patent | 26.07.1996 | Fee for grant paid | 26.07.1996 | Fee for publishing/printing paid | Opposition(s) | 13.12.1997 | No opposition filed within time limit [1998/10] | Fees paid | Renewal fee | 07.12.1994 | Renewal fee patent year 03 | 08.12.1995 | Renewal fee patent year 04 | 23.12.1996 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||